what are the Recommendations for Antithrombotic Therapy for Prosthetic Valves
(Continued)?
For patients with a bioprosthetic TAVI who are at low risk of bleeding, dual- antiplatelet therapy with aspirin 75 to 100 mg and clopidogrel 75 mg may be reasonable for 3 to 6 months after valve implantation.